What is the market valuation of radiotherapy?

In 2027 the market for radiotherapy is valued at USD 8.53 Billion.

How much is the radiotherapy industry expected to grow by 2036?

Radiotherapy Market size stood at USD 8.09 Billion in 2026 and is predicted to grow at 6.36% CAGR from 2027 to 2036, surpassing USD 14.99 Billion by 2036.

How are precision radiotherapy technologies influencing treatment adoption?

Advances in imaging integration, adaptive therapy, treatment planning, and targeted radiation delivery improve treatment precision while minimizing exposure to healthy tissue, supporting personalized oncology care and broader clinical adoption.

Why are healthcare infrastructure investments important for radiotherapy market expansion?

Investments in oncology infrastructure, cancer centers, and radiation treatment capacity are expanding access to advanced radiotherapy systems, enabling healthcare providers to serve larger patient populations with integrated cancer care services.

Why is External Beam Radiation Therapy the leading type in the radiotherapy market?

External Beam Radiation Therapy accounted for 62.3% of the market in 2026 due to broad clinical use, advanced treatment planning, and its ability to deliver precise radiation while minimizing damage to healthy tissues.

Which application segment is expected to grow the fastest in the radiotherapy market?

Prostate cancer is projected to be the fastest-growing application as advanced radiation techniques enable more precise treatment, fewer side effects, and greater adoption of non-invasive cancer therapies.

Why does North America lead the radiotherapy market?

North America leads due to advanced oncology infrastructure, broad access to sophisticated radiation technologies, and substantial healthcare investment supporting precision-based cancer care.

What is driving radiotherapy market growth in Asia Pacific?

Asia Pacific is the fastest-growing region, supported by rising cancer burden, improving healthcare infrastructure, expanding treatment facilities, and greater investment in advanced oncology services.

Which companies dominate the radiotherapy landscape?

Leading companies in the radiotherapy market include Elekta AB (Sweden), Accuray Incorporated (United States), Brainlab AG (Germany), Canon Medical Systems Corporation (Japan), Mitsubishi Electric Corporation (Japan), Toshiba Energy Systems & Solutions Corporation (Japan), Mevion Medical Systems, Inc. (United States), RefleXion Medical, Inc. (United States), Ion Beam Applications S.A. (Belgium)